Which Medical Conditions Account for the Rise in Health Care Spending?

Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Health Affairs (Impact Factor: 4.32). 09/2004; Suppl Web Exclusives(5):W4-437-45. DOI: 10.1377/hlthaff.w4.437
Source: PubMed

ABSTRACT We calculate the level and growth in health care spending attributable to the fifteen most expensive medical conditions in 1987 and 2000. Growth in spending by medical condition is decomposed into changes attributable to rising cost per treated case, treated prevalence, and population growth. We find that a small number of conditions account for most of the growth in health care spending--the top five medical conditions accounted for 31 percent. For four of the conditions, a rise in treated prevalence, rather than rising treatment costs per case or population growth, accounted for most of the spending growth.

Download full-text


Available from: Curtis Florence, Jul 15, 2014
  • Source
    • "Some medical research shows that smoking leads to lung cancer, laryngeal cancer, asthma, and cardiovascular diseases [16, 17, 26–29]. Compared to those who do not smoke, smokers have shorter life expectancy and incur higher medical expenditure [14] [16] [19] [29] [30], and the people who are affected by secondhand smoke also tend to incur higher medical expenditure [25] [31]. Moreover, although appropriate drinking does no harm personal health [32] [33] [34] [35], excessive drinking increases the numbers of accidents and the morbidity of liver cancer. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We investigate the effect of different scales of addictive factors on the utilization of medical services in this paper using a two-part model. Data are from the 2005 National Health Interview Survey and the claims data in the National Health Insurance Research Database in Taiwan. The results show that personal addictive behavior is significantly associated with both outpatient and inpatient utilization. Moreover, our result implies that those who smoked at least 20 cigarettes per day might not visit a doctor until the illness was severe. It suggests that the government can accomplish these goals by promotion and education in order to increase public awareness of personal health.
    01/2012; 2012(2090-2123). DOI:10.1155/2012/801204
  • Source
    • "Economic costs related to overweight and obesity were estimated to be $99.2 billion as of 1995 (Wolf and Colditz, 1998), and more recently this estimate has risen to $117 billion (USDHHS, 2001). This is especially a major concern for the public, as obesity-related illnesses have contributed to the overall growth in health care spending (Thorpe et al., 2004). Social costs of obesity being higher than private costs are grounds for possible government intervention. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The escalating rate of obesity in the US highlights the importance of understanding the causes for this rise. In this paper I employ the First, Second, and Third National Health and Nutrition Examination Surveys to estimate a structural model of the determinants of adult obesity. To control for the potential endogeneity of some explanatory variables, such as caloric intake (adjusted for activity level) and smoking, a set of reduced form equations for these outcomes is estimated simultaneously with the obesity equation. To identify each equation, I use an array of state-level characteristics as instrumental variables. Trends in these variables shed light on the sources of the rapid increase in obesity since 1980.
    The Quarterly Review of Economics and Finance 05/2006; 46(2-46):268-283. DOI:10.1016/j.qref.2005.11.002
  • Source
    • "new diagnostic and imaging procedures, and new treatments and therapies have all led millions more to seek treatment for their health conditions (Thorpe et al., 2004). Especially important was the introduction of many new classes of prescription drugs, such as lipid-lowering statins and new types of anti-depressants like Prozac and Paxil. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Consumers' price responsiveness is central to US health-care reform proposals, but the best available estimates are now more than 25 years old. We estimate health-care demands by calculating expected end-of-year prices and incorporating them into a zero-inflated ordered probit model applied to several overlapping panels of data from 1996 to 2003. Results from our correlated random effects specification indicate that the price responsiveness of ambulatory mental health treatment has decreased substantially and is now slightly lower than physical health treatment. This suggests that concerns over moral hazard alone do not warrant less generous coverage for mental health. However, prescription drug demand is more price elastic.
    Health Economics 01/2006; 19(3):297-315. DOI:10.1002/hec.1476 · 2.14 Impact Factor
Show more